Get startedLog in
    Picture of Genmab A/S logo

    GMAB — Genmab A/S News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Genmab nears deal to acquire Dutch cancer drugmaker Merus, Bloomberg News reports

    Picture of Genmab A/S logoGenmab A/S
    28/09/2025 23:25
    Sept 28 (Reuters) - Denmark’s Genmab GMAB.CO is in advanced talks to acquire Merus NV 2GH.F, a Nasdaq-listed Dutch biotech firm developing a head-and-neck cancer drug, Bloomberg News reported on Sunday.

 (Reporting by Rajveer Singh Pardesi in Bengaluru; Editing by Leslie Adler)

 ((RajveerSingh.Pardesi@thomsonreuters.com;))

    Recent news on Genmab A/S

    See all news